6 min read
This Holiday Season, Veristat is continuing its tradition of participating in the Movement to Beat Rare Cancers!
On behalf of all of our clients, Veristat has made a $12,500 donation to one of the many organizations that we supported this year and will support in 2017, Cycle for Survival. In addition, our employees have committed to raising over $25,000.
Join The Battle!
Help cure rare cancers by donating today!
About Cycle for Survival
Cycle for Survival is the national movement to beat rare cancers. About half of all cancer patients are fighting a rare cancer -- Leukemia, lymphoma, pancreatic cancer, bladder cancer, ovarian cancer, and all pediatric cancers are just some of the many rare forms of the disease. These patients often face limited or no treatment options.
This is where Cycle for Survival comes in:
- 100% of every dollar raised funds pioneering research led by Memorial Sloan Kettering, the world's oldest and largest private cancer center.
- $106M has been raised by Cycle for Survival since 2007 to beat rare cancers.
- 100+ clinical trials, research studies, and major research initiatives have been funded by Cycle for Survival.
"VERISTAT WISHES YOU A HAPPY HOLIDAY SEASON AND A HAPPY NEW YEAR FILLED WITH HEALTH, HAPPINESS, AND SUCCESS!"
- From All of Us at Veristat!
Get the Latest News
Categories
- Regulatory Consulting (119)
- Regulatory Submissions (114)
- Clinical Trial Regulations (99)
- COVID-19 (46)
- Strategic Consulting (30)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Success Stories (13)
- Oncology (11)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Clinical Operations/Monitoring (8)
- Medical Writing (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
2 min read
ASCO Annual Meeting
Apr 23, 2025 Veristat Events
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...